Sarcoidosis Therapeutics - Pipeline Assessment and

Market Forecasts to 2019

On 30thDecember 2014

Summary
The industry analysis specialist, has released its new report, Sarcoidosis Therapeutics Pipeline Assessment and Market Forecasts to 2019. The report is an essential source of
information and analysis on the global Sarcoidosis Therapeutics market. The report identifies
the key trends shaping and driving the global Sarcoidosis Therapeutics market. The report also
provides insights on the prevalent competitive landscape and the emerging players expected to
significantly alter the market positioning of the current market leaders. Most importantly, the
report provides valuable insights on the pipeline products within the global Sarcoidosis
Therapeutics sector. This report is built using data and information sourced from proprietary
databases, primary and secondary research and in-house analysis by GlobalDatas team of
industry experts.

You can buy this Report @ http://www.jsbmarketresearch.com/healthcaremedical/r-sarcoidosis-therapeutics-pipeline-assessment-and-market-forecasts135209

Scope
The report provides information on the key drivers and challenges of the Sarcoidosis
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Therapeutics market. Its scope includes - Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Sarcoidosis
Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being
developed and emerging trends by seven key markets. Pipeline candidates fall under major
therapeutic classes.
- Analysis of the current and future competition in the seven key countries Sarcoidosis
Therapeutics market.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is
independently researched to provide a qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet
needs and the implications for the Sarcoidosis Therapeutics market.
- Analysis of key recent licensing and partnership agreements in Sarcoidosis Therapeutics
market

Reasons to buy
The report will enhance your decision making capability. It will allow you to - Develop and design your in-licensing and out-licensing strategies through a review of pipeline
products and technologies and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global
Sarcoidosis Therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies,
market segments and companies likely to impact the global Sarcoidosis Therapeutics market in
future.
- Formulate effective sales and marketing strategies by understanding the competitive
landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective
counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments
that present maximum opportunities for consolidations, investments and strategic
partnerships.
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

- Whats the next big thing in the global Sarcoidosis Therapeutics market landscape? Identify,
understand and capitalize

Other industries we cover:

Advertising and Media

Automotive and Parts
Consumer Goods
Healthcare and Medical
Finance and Banking
Food and Beverages
Travel and Tourism
Textiles and Clothing
SWOT Analysis

Discounts on Market Research Reports till 31st December, 2014

For more inquiries, contact at +91 - 998 729 5242 /
contact@jsbmarketresearch.com

Table of Content
2 Sarcoidosis Therapeutics - Introduction
2.1 Overview
2.2 Epidemiology
2.3 Etiology
2.4 Symptoms
2.4.1 Lung Related Symptoms
2.4.2 Lymph Node Related Symptoms
2.4.3 Spleen Related Symptoms
2.4.4 Liver Related Symptoms
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

2.4.5 Heart Related Symptoms

2.4.6 Brain and Nervous System Related Symptoms
2.4.7 Eyes Related Symptoms
2.4.8 Musculoskeletal System Related Symptoms
2.5 Diagnosis
2.5.1 Initial Examination
2.5.2 X-rays
2.5.3 Biopsy
2.5.4 Imaging Techniques
2.5.5 Other Tests Related to Lungs, Heart, Brain and Nervous System
2.6 Pathophysiology
2.7 Treatment and Management Pattern
2.8 GlobalData Pipeline Report Guidance
3 Sarcoidosis Therapeutics - Market Characterization
3.1 Sarcoidosis Therapeutics Market Size (2006-2011) - Global
3.2 Sarcoidosis Therapeutics Market Forecast (2011-2019) - Global
3.3 Sarcoidosis Therapeutics Market Size (2006-2011) - The US
3.4 Sarcoidosis Therapeutics Market Forecast (2011-2019) - The US
3.5 Sarcoidosis Therapeutics Market Size (2006-2011) - France
3.6 Sarcoidosis Therapeutics Market Forecast (2011-2019) - France
3.7 Sarcoidosis Therapeutics Market Size (2006-2011) - Germany
3.8 Sarcoidosis Therapeutics Market Forecast (2011-2019) - Germany
3.9 Sarcoidosis Therapeutics Market Size (2006-2011) - Italy
3.10 Sarcoidosis Therapeutics Market Forecast (2011-2019) - Italy
3.11 Sarcoidosis Therapeutics Market Size (2006-2011) - Spain
3.12 Sarcoidosis Therapeutics Market Forecast (2011-2019) - Spain
3.13 Sarcoidosis Therapeutics Market Size (2006-2011) - The UK
3.14 Sarcoidosis Therapeutics Market Forecast (2011-2019) - The UK
3.15 Sarcoidosis Therapeutics Market Size (2006-2011) - Japan
3.16 Sarcoidosis Therapeutics Market Forecast (2011-2019) - Japan
3.17 Drivers and Barriers for the Sarcoidosis Therapeutics Market
3.17.1 Drivers for the Sarcoidosis Therapeutics Market
3.17.2 Barriers for the Sarcoidosis Therapeutics Market
3.18 Opportunity and Unmet Need
3.19 Key Takeaway
4 Sarcoidosis Therapeutics - Competitive Assessment
4.1 Overview
4.2 Strategic Competitor Assessment
4.3 Product Profile for Major Marketed Products in the Sarcoidosis Therapeutics Market
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

4.3.1 Corticosteroids
4.3.2 Immunosuppressant Drugs
4.3.3 TNF-alpha Blockers
4.3.4 Miscellaneous Agents
4.4 Key Takeaway
5 Sarcoidosis Therapeutics - Pipeline Assessment
5.1 Overview
5.2 Strategic Pipeline Assessment
5.3 Sarcoidosis Therapeutics - Pipeline Analysis by Phase of Development
5.3.1 Sarcoidosis Therapeutics - Phase III Pipeline
5.3.2 Sarcoidosis Therapeutics - Phase II Pipeline
5.3.3 Sarcoidosis Therapeutics - Phase I Pipeline
5.4 Sarcoidosis Therapeutics - Pipeline by Mechanism of Action
5.5 Technology Trends Analytical Framework
5.6 Pipeline Drug Description
5.6.1 DasKloster 0112-01
5.6.2 Stelara (ustekinumab)
5.6.3 Simponi (golimumab)
5.7 Key Takeaway
6 Sarcoidosis Therapeutics - Clinical Trials Mapping
6.1 Clinical Trials by Region and Country
6.2 Clinical Trials by Phase of Clinical Development
6.3 Clinical Trials by Trial Status
6.4 Clinical Trials by Sponsors
6.5 Top Companies Participating in Sarcoidosis Clinical Trials
7 Sarcoidosis Therapeutics - Strategic Assessment
7.1 Key Events Impacting the Future Market
7.2 Future Market Competition Scenario
8 Sarcoidosis Therapeutics - Future Players
8.1 Introduction
8.2 Company Profiles
8.2.1 Mondobiotech Holding AG
8.2.2 Johnson & Johnson
8.2.3 Celgene Corporation
8.3 Key Takeaway
9 Sarcoidosis Therapeutics - Licensing and Partnership Deals
10 Sarcoidosis Therapeutics - Appendix
10.1 Definitions
10.2 Acronyms
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

10.3 Research Methodology

10.3.1 Coverage
10.3.2 Secondary Research
10.3.3 Forecasting
10.3.4 Primary Research
10.3.5 Expert Panel Validation
10.4 Contact Us
10.5 Disclaimer
10.6 Bibliography

List Of Tables
Table 1: Sarcoidosis - Initial Therapy According to Organ and Clinical Status
Table 2: Sarcoidosis Therapeutics Market, Global, Revenue ($m), 2006-2011
Table 3: Sarcoidosis Therapeutics Market, Global, Forecast ($m), 2011-2019
Table 4: Sarcoidosis Therapeutics Market, The US, Revenue ($m), 2006-2011
Table 5: Sarcoidosis Therapeutics Market, The US, Forecast ($m), 2011-2019
Table 6: Sarcoidosis Therapeutics Market, France, Revenue ($m), 2006-2011
Table 7: Sarcoidosis Therapeutics Market, France, Forecast ($m), 2011-2019
Table 8: Sarcoidosis Therapeutics Market, Germany, Revenue ($m), 2006-2011
Table 9: Sarcoidosis Therapeutics Market, Germany, Forecast ($m), 2011-2019
Table 10: Sarcoidosis Therapeutics Market, Italy, Revenue ($m), 2006-2011
Table 11: Sarcoidosis Therapeutics Market, Italy, Forecast ($m), 2011-2019
Table 12: Sarcoidosis Therapeutics Market, Spain, Revenue ($m), 2006-2011
Table 13: Sarcoidosis Therapeutics Market, Spain, Forecast ($m), 2011-2019
Table 14: Sarcoidosis Therapeutics Market, The UK, Revenue ($m), 2006-2011
Table 15: Sarcoidosis Therapeutics Market, The UK, Forecast ($m), 2011-2019
Table 16: Sarcoidosis Therapeutics Market, Japan, Revenue ($m), 2006-2011
Table 17: Sarcoidosis Therapeutics Market, Japan, Forecast ($m), 2011-2019
Table 18: Sarcoidosis Therapeutics - Phase III Clinical Pipeline, 2011
Table 19: Sarcoidosis Therapeutics - Phase II Clinical Pipeline, 2011
Table 20: Sarcoidosis Therapeutics - Phase I Clinical Pipeline, 2011
Table 21: Sarcoidosis Therapeutics, Global, Clinical Trials, 2011
Table 22: Sarcoidosis Therapeutics, Global, Clinical Trials by Phase, 2011
Table 23: Sarcoidosis Therapeutics, Global, Clinical Trials by Status of Development, 2011
Table 24: Sarcoidosis Therapeutics, Global, Overall Sponsors, 2011
Table 25: Sarcoidosis Therapeutics, Global, Prominent Sponsors, 2011
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Table 26: Sarcoidosis Therapeutics, Global, Top Ten Companies by Phase, 2011
Table 27: Mondobiotech Holding AG - Sarcoidosis Pipeline, 2011
Table 28: Johnson & Johnson - Sarcoidosis Pipeline, 2011
Table 29: Celgene Corporation - Sarcoidosis Pipeline, 2011
Table 30: Sarcoidosis Therapeutics, Global, Deals, 2011

List Of Figures
Figure 1: Sarcoidosis - Agents Involved in Etiology of Sarcoidosis
Figure 2: Sarcoidosis - Involvement of Various Organs
Figure 3: Sarcoidosis - Pathophysiology of Granulomas Formation
Figure 4: Sarcoidosis Therapeutics Market, Global, Revenue ($m), 2006-2011
Figure 5: Sarcoidosis Therapeutics Market, Global, Forecast ($m), 2011-2019
Figure 6: Sarcoidosis Therapeutics Market, The US, Revenue ($m), 2006-2011
Figure 7: Sarcoidosis Therapeutics Market, The US, Forecast ($m), 2011-2019
Figure 8: Sarcoidosis Therapeutics Market, France, Revenue ($m), 2006-2011
Figure 9: Sarcoidosis Therapeutics Market, France, Forecast ($m), 2011-2019
Figure 10: Sarcoidosis Therapeutics Market, Germany, Revenue ($m), 2006-2011
Figure 11: Sarcoidosis Therapeutics Market, Germany, Forecast ($m), 2011-2019
Figure 12: Sarcoidosis Therapeutics Market, Italy, Revenue ($m), 2006-2011
Figure 13: Sarcoidosis Therapeutics Market, Italy, Forecast ($m), 2011-2019
Figure 14: Sarcoidosis Therapeutics Market, Spain, Revenue ($m), 2006-2011
Figure 15: Sarcoidosis Therapeutics Market, Spain, Forecast ($m), 2011-2019
Figure 16: Sarcoidosis Therapeutics Market, The UK, Revenue ($m), 2006-2011
Figure 17: Sarcoidosis Therapeutics Market, The UK, Forecast ($m), 2011-2019
Figure 18: Sarcoidosis Therapeutics Market, Japan, Revenue ($m), 2006-2011
Figure 19: Sarcoidosis Therapeutics Market, Japan, Forecast ($m), 2011-2019
Figure 20: Opportunity and Unmet Need in the Sarcoidosis Therapeutics Market, 2011
Figure 21: Strategic Competitor Assessment of the Marketed Products in Sarcoidosis
Therapeutics, 2011
Figure 22: Sarcoidosis- Clinical Pipeline by Phase of Development (%), 2011
Figure 23: Sarcoidosis Therapeutics, Clinical Pipeline by Mechanism of Action (%), 2011
Figure 24: Technology Trends Analytics Framework, 2011
Figure 25: Technology Trends Analytics Framework - Description, 2011
Figure 26: Sarcoidosis Therapeutics, Global, Clinical Trials by Country, 2011
Figure 27: Sarcoidosis Therapeutics, Global, Clinical Trials by Phase (%), 2011
Figure 28: Sarcoidosis Therapeutics, Global, Clinical Trials by Status of Development (%), 2011
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Figure 29: Sarcoidosis Therapeutics, Global, Overall Sponsors (%), 2011

Figure 30: Sarcoidosis Therapeutics, Global, Prominent Sponsors (%), 2011
Figure 31: Sarcoidosis Therapeutics, Global, Top Companies by Phase, 2011
Figure 32: Sarcoidosis Therapeutics Market, Drivers and Barriers, 2011
Figure 33: Implications for Future Market Competition in the Sarcoidosis Therapeutics Market,
2011
Figure 34: Sarcoidosis Therapeutics Market, Clinical Pipeline by Company, 2011
Figure 35: GlobalData Market Forecasting Model

Report Price:
Licence Type

Price

PDF

$ 3995

Site Licence

$ 7990

Enterprise Wide Licence

$ 11985

Related Reports:
Respiratory Syncytial Virus (RSV) Prophylactic - Pipeline Assessment and Market Forecasts to 2019
Vaginitis Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Clostridium difficile Infection (CDI) Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Atherosclerosis or Coronary Artery Disease (CAD) Therapeutics - Pipeline Assessment and Market
Forecasts to 2018
Unstable Angina Therapeutics - Pipeline Assessment and Market Forecast to 2018
Venous Thromboembolism (VTE) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Pulmonary Embolism (PE) Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Vitiligo Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Chronic Urticaria or Hives Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Peptic Ulcer Therapeutics- Pipeline Assessment and Market Forecasts to 2018

You can order this report by calling on +91 - 998 7295 242 or mail us
your contact details at contact@jsbmarketresearch.com

About JSB Market Research:JSB market research is a leading player in the market of research report distribution. It is onestop-shop for all information related to market research for any sector of the industry. Along
with providing in-depth analysis though reports, JSB market research also provides regular
updates of the market though newsletters. Our reports are a well-researched work of market
researchers with an extensive knowledge and a good level of market experience.

To know more on Sarcoidosis Therapeutics - Pipeline Assessment and Market

Forecasts to 2019
http://www.jsbmarketresearch.com/healthcare-medical/r-sarcoidosistherapeutics-pipeline-assessment-and-market-forecasts-135209

Email ID- contact@jsbmarketresearch.com

Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/